A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

7.2K views

⸱

DOI:

10.3791/59107

⸱

May 23rd, 2019

In This Article

Summary

Here, we present a protocol to induce and score disease in a xenogeneic graft-versus-host disease (xenoGVHD) model. xenoGVHD provides an in vivo model to study immunosuppression of human T cells. Additionally, we describe how to detect human T cells in tissues with digital PCR as a tool to quantify immunosuppression.

Abstract

Acute graft-versus-host disease (GVHD) is a significant limitation for patients receiving hematopoietic stem cell transplant as therapy for hematological deficiencies and malignancies. Acute GVHD occurs when donor T cells recognize host tissues as a foreign antigen and mount an immune response to the host. Current treatments involve toxic immunosuppressive drugs that render patients susceptible to infection and recurrence. Thus, there is ongoing research to provide an acute GVHD therapy that can effectively target donor T cells and reduce side effects. Much of this pre-clinical work uses the xenogenic GVHD (xenoGVHD) murine model that allows for testing of immunosuppressive therapies on human cells rather than murine cells in an in vivo system. This protocol outlines how to induce xenoGVHD and how to blind and standardize clinical scoring to ensure consistent results. Additionally, this protocol describes how to use digital PCR to detect human T cells in mouse tissues, which can subsequently be used to quantify efficacy of tested therapies. The xenoGVHD model not only provides a model to test GVHD therapies but any therapy that can suppress human T cells, which could then be applied to many inflammatory diseases.

Introduction

Allogeneic hematopoietic stem cell transplant (HSCT) has become routine treatment for patients suffering from hematological malignancies such as leukemia with poor prognosis. A significant complication of HSCT is acute graft-versus-host disease (GVHD). A 2012 study reported that acute GVHD developed in 39% of HSCT patients receiving transplants from sibling donors and 59% of patients receiving transplants from unrelated donors1. Acute GVHD occurs when donor-derived T cells attack recipient’s organs. The only successful therapy for GVHD is treatment with highly immunosuppressive drugs2, which are highly toxic and in....

Access restricted. Please log in or start a trial to view this content.

Protocol

All mouse experiments were performed in compliance, and with approval from, the University of Kansas Medical Center Institutional Animal Care and Use Committee. All healthy human blood samples were obtained under informed consent and with approval from the Institutional Review Board at the University of Kansas Medical Center.

1. Irradiation of NSG Mice

  1. One day prior to PBMC injection, irradiate 8–12-week old NSG mice (either sex can be used). In a sterile biosafety cabinet, place mice in a sterilized pie cage or microisolator. Irradiate mice in a Cs137 source or small animal irradiator (e.g., RS 2000) with a tot....

Access restricted. Please log in or start a trial to view this content.

Results

Sublethally irradiated 8-12-week old NSG mice of both sexes that received human PBMC started displaying clinical signs of GVHD around day 10 post injection compared to negative control mice that received PBS only (Figure 1A). XenoGVHD mice had a median survival of 23.5 days (Figure 1B). With digital PCR, CD3 epsilon positive human T cells could be detected in the lung and liver samples of mice that received human PBMC. Tissue sam.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Disease progression is generally consistent in the xenoGVHD model, even with injection of PBMC from different donors, so multiple experiments can be combined. The key steps required to maintain this consistency are proper i.v. injection technique, blinding and consistent scoring. A study by Nervi et al.25 demonstrated that compared to intravenous tail vein injection, retro-orbital injections of PBMC resulted in more consistent engraftment and more severe GVHD. Leon-Rico et al.26<.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Acknowledgements

We would like to acknowledge the laboratory of Lane Christenson for providing the digital PCR machine used in these experiments and for the technical support provided. We would also like to thank Dr. Thomas Yankee for his guidance and mentorship. These studies were supported by the Tripp Family Foundation.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1.5 mL eppendorf tubesFisher05-408-129
10 mL serological pipetVWR International89130-898
10mL BD Vacutainers - Green capped with Sodium HeparinBecton Dickinson366480
250 µL Ranin pipette tipsRainin17001118Do not use other pipettes or pipet tips for droplet generation
50 mL conical tubeVWR International89039-656
96-Well ddPCR plateBio-Rad12001925
ACK (Ammonium-Chloride-Potassium) Lysing BufferLonza10-548EOptional
Alcohol WipesFisher Scientific6818
Anesthesia ChamberWorld Precision InstrumentsEZ-178Provided by animal facility
Anesthesia MachineParkland ScientificPM1002Provided by animal facility
BD Vacutainer Safety-Lok Blood Collection SetBecton Dickinson367281
DG8 Cartridges and Gaskets for QX100/QX200 Droplet GeneratorBio-Rad1864007
DNAse and RNAse free Molecular Grade H2OLife Technologies1811318
Ethyl alcohol, Pure,200 proof, for molecular biologySigma-AldrichE7023-500ML
Fetal Bovine SerumAtlanta BiologicalsS11150
FicollFisher Scientific45001750
Insulin SyringeFisher Scientific329424
IsofluraneSigma-AldrichCDS019936Provided by animal facility
Liquid nitrogenN/AN/A
Mouse Irradiator Pie CageBraintree Scientific, Inc.MPC 1Holds up to 11 mice
Nexcare Gentle Paper Tape (a.k.a. 3M Micropore Surgical Tape / 3/4")Fisher Scientific19-027-761
P1000 pipetmanMidSciA-1000
P200 pipetmanMidSciA-200
Pierceable Foil Heat SealBio-Rad1814040
Pipetaid Gilson MacromanFisher ScientificF110756
Pipet-Lite Multi Pipette L8-200XLS+Rainin17013805Do not use other pipettes or pipet tips for droplet generation
Qiagen DNeasy Blood and Tissue KitQiagen69506
qPCR platesVWR International89218-292
QX200 Droplet Digital PCR SystemBio-Rad12001925Includes droplet generator, droplet reader, laptop computer, software, associated component consumables, for EvaGreen or probe-based digital PCR applications
QX200 Droplet Generation Oil for EvaGreenBio-Rad1864006
QX200 ddPCR EvaGreen SupermixBio-Rad1864033
RNase and DNase-free plate sealThermo Scientific12565491
RPMI Advanced 1640Life Technologies12633012
Sterile Gauze Pads (2" x 2", 12-Ply)Fisher Scientific67522
Sterile Phosphate Buffered SalineFisher Scientific21040CV
Sterile reservoirVWR International89094-662
Surgial ScissorsKent ScientificINS600393-4
Surgical ForcepsKent ScientificINS650914-4

References

  1. Jagasia, M., et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 119 (1), 296-307 (2012).
  2. Bolanos-Meade, J., et al. Phase 3 clinical trial of steroids/mycophenolate ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Human T Cell QuantificationPeripheral Blood Mononuclear CellsStromal Vascular FractionFlow CytometryClinical ScoringTissue DigestionCell Isolation